2023-2029 Global Population Screening Industry Research & Trends Analysis Report
Population screening is the process of assessing the prevalence of a particular trait in the entire population or in a subgroup of the population. Screening is the process of identifying healthy people who may have an increased chance of a disease or condition. The screening provider then offers information, further tests and treatment. This is to reduce associated problems or complications. Population screening is being adopted as a major strategy owing to benefits such as early patient identification, which can help reduce the burden of the higher treatment cost of diseases at later stages.
This report aims to provide a comprehensive study of the global market for Population Screening. Report Highlights:
(1) Global Population Screening market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Population Screening market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Population Screening market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Population Screening segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Population Screening segment by type and by application and regional segment by type and by application.
(6) Population Screening industry supply chain, upstream, midstream and downstream analysis.
According to YH Research, the global market for Population Screening should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Population Screening market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Population Screening market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Hardware Equipment (Instrument, Kits, Chips) segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospitals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Population Screening include Agilent Technologies, Inc., ARUP Laboratories, F. Hoffmann-La Roche Ltd., Gene by Gene, Ltd., Illumina, Inc., QIAGEN, Quest Diagnostics, LGC Limited and Novogene Co., Ltd., etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Hardware Equipment (Instrument, Kits, Chips)
Testing / Lab (Services)
Analytics / Interpretation (Personalization And Interpretation)
Market segment by application, can be divided into
Hospitals
Research Institutes
Diagnostic Labs
Market segment by players, this report covers
Agilent Technologies, Inc.
ARUP Laboratories
F. Hoffmann-La Roche Ltd.
Gene by Gene, Ltd.
Illumina, Inc.
QIAGEN
Quest Diagnostics
LGC Limited
Novogene Co., Ltd.
Thermo Fisher Scientific, Inc.
1 Market Overview
1.1 Product Overview and Scope of Population Screening
1.2 Global Population Screening Market Size and Forecast
1.3 China Population Screening Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Population Screening Share in Global Market, 2018-2029
1.4.2 Population Screening Market Size: China VS Global, 2018-2029
1.5 Population Screening Market Dynamics
1.5.1 Population Screening Market Drivers
1.5.2 Population Screening Market Restraints
1.5.3 Population Screening Industry Trends
1.5.4 Population Screening Industry Policy
2 Global Competitive Situation by Company
2.1 Global Population Screening Revenue by Company (2018-2023)
2.2 Global Population Screening Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Population Screening Concentration Ratio
2.4 Global Population Screening Mergers & Acquisitions, Expansion Plans
2.5 Global Population Screening Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Population Screening Revenue by Company (2018-2023)
3.2 China Population Screening Population Screening Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Population Screening, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Population Screening Industry Chain
4.2 Population Screening Upstream Analysis
4.3 Population Screening Midstream Analysis
4.4 Population Screening Downstream Analysis
5 Sights by Type
5.1 Population Screening Classification
5.1.1 Hardware Equipment (Instrument, Kits, Chips)
5.1.2 Testing / Lab (Services)
5.1.3 Analytics / Interpretation (Personalization And Interpretation)
5.2 By Type, Global Population Screening Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Population Screening Revenue, 2018-2029
6 Sights by Application
6.1 Population Screening Segment by Application
6.1.1 Hospitals
6.1.2 Research Institutes
6.1.3 Diagnostic Labs
6.2 By Application, Global Population Screening Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Population Screening Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Population Screening Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Population Screening Market Size, 2018-2029
7.3 North America
7.3.1 North America Population Screening Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Population Screening Market Size Market Share
7.4 Europe
7.4.1 Europe Population Screening Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Population Screening Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Population Screening Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Population Screening Market Size Market Share
7.6 South America
7.6.1 South America Population Screening Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Population Screening Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Population Screening Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Population Screening Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Population Screening Market Size, 2018-2029
8.3.2 By Company, U.S. Population Screening Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Population Screening Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Population Screening Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Population Screening Market Size, 2018-2029
8.4.2 By Company, Europe Population Screening Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Population Screening Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Population Screening Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Population Screening Market Size, 2018-2029
8.5.2 By Company, China Population Screening Revenue Market Share, 2018-2023
8.5.3 By Type, China Population Screening Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Population Screening Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Population Screening Market Size, 2018-2029
8.6.2 By Company, Japan Population Screening Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Population Screening Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Population Screening Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Population Screening Market Size, 2018-2029
8.7.2 By Company, South Korea Population Screening Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Population Screening Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Population Screening Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Population Screening Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Population Screening Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Population Screening Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Population Screening Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Population Screening Market Size, 2018-2029
8.9.2 By Company, India Population Screening Revenue Market Share, 2018-2023
8.9.3 By Type, India Population Screening Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Population Screening Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Population Screening Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Population Screening Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Population Screening Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Population Screening Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Agilent Technologies, Inc.
9.1.1 Agilent Technologies, Inc. Company Information, Head Office, Market Area and Industry Position
9.1.2 Agilent Technologies, Inc. Company Profile and Main Business
9.1.3 Agilent Technologies, Inc. Population Screening Models, Specifications and Application
9.1.4 Agilent Technologies, Inc. Population Screening Revenue and Gross Margin, 2018-2023
9.1.5 Agilent Technologies, Inc. Recent Developments
9.2 ARUP Laboratories
9.2.1 ARUP Laboratories Company Information, Head Office, Market Area and Industry Position
9.2.2 ARUP Laboratories Company Profile and Main Business
9.2.3 ARUP Laboratories Population Screening Models, Specifications and Application
9.2.4 ARUP Laboratories Population Screening Revenue and Gross Margin, 2018-2023
9.2.5 ARUP Laboratories Recent Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position
9.3.2 F. Hoffmann-La Roche Ltd. Company Profile and Main Business
9.3.3 F. Hoffmann-La Roche Ltd. Population Screening Models, Specifications and Application
9.3.4 F. Hoffmann-La Roche Ltd. Population Screening Revenue and Gross Margin, 2018-2023
9.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
9.4 Gene by Gene, Ltd.
9.4.1 Gene by Gene, Ltd. Company Information, Head Office, Market Area and Industry Position
9.4.2 Gene by Gene, Ltd. Company Profile and Main Business
9.4.3 Gene by Gene, Ltd. Population Screening Models, Specifications and Application
9.4.4 Gene by Gene, Ltd. Population Screening Revenue and Gross Margin, 2018-2023
9.4.5 Gene by Gene, Ltd. Recent Developments
9.5 Illumina, Inc.
9.5.1 Illumina, Inc. Company Information, Head Office, Market Area and Industry Position
9.5.2 Illumina, Inc. Company Profile and Main Business
9.5.3 Illumina, Inc. Population Screening Models, Specifications and Application
9.5.4 Illumina, Inc. Population Screening Revenue and Gross Margin, 2018-2023
9.5.5 Illumina, Inc. Recent Developments
9.6 QIAGEN
9.6.1 QIAGEN Company Information, Head Office, Market Area and Industry Position
9.6.2 QIAGEN Company Profile and Main Business
9.6.3 QIAGEN Population Screening Models, Specifications and Application
9.6.4 QIAGEN Population Screening Revenue and Gross Margin, 2018-2023
9.6.5 QIAGEN Recent Developments
9.7 Quest Diagnostics
9.7.1 Quest Diagnostics Company Information, Head Office, Market Area and Industry Position
9.7.2 Quest Diagnostics Company Profile and Main Business
9.7.3 Quest Diagnostics Population Screening Models, Specifications and Application
9.7.4 Quest Diagnostics Population Screening Revenue and Gross Margin, 2018-2023
9.7.5 Quest Diagnostics Recent Developments
9.8 LGC Limited
9.8.1 LGC Limited Company Information, Head Office, Market Area and Industry Position
9.8.2 LGC Limited Company Profile and Main Business
9.8.3 LGC Limited Population Screening Models, Specifications and Application
9.8.4 LGC Limited Population Screening Revenue and Gross Margin, 2018-2023
9.8.5 LGC Limited Recent Developments
9.9 Novogene Co., Ltd.
9.9.1 Novogene Co., Ltd. Company Information, Head Office, Market Area and Industry Position
9.9.2 Novogene Co., Ltd. Company Profile and Main Business
9.9.3 Novogene Co., Ltd. Population Screening Models, Specifications and Application
9.9.4 Novogene Co., Ltd. Population Screening Revenue and Gross Margin, 2018-2023
9.9.5 Novogene Co., Ltd. Recent Developments
9.10 Thermo Fisher Scientific, Inc.
9.10.1 Thermo Fisher Scientific, Inc. Company Information, Head Office, Market Area and Industry Position
9.10.2 Thermo Fisher Scientific, Inc. Company Profile and Main Business
9.10.3 Thermo Fisher Scientific, Inc. Population Screening Models, Specifications and Application
9.10.4 Thermo Fisher Scientific, Inc. Population Screening Revenue and Gross Margin, 2018-2023
9.10.5 Thermo Fisher Scientific, Inc. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Population Screening Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Population Screening Market Restraints
Table 3. Population Screening Market Trends
Table 4. Population Screening Industry Policy
Table 5. Global Population Screening Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Population Screening Revenue Market Share by Company (2018-2023)
Table 7. Global Population Screening Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Population Screening Mergers & Acquisitions, Expansion Plans
Table 9. Global Population Screening Manufacturers Product Type
Table 10. China Population Screening Revenue by Company (2018-2023) & (US$ million)
Table 11. China Population Screening Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Population Screening Upstream (Raw Materials)
Table 13. Global Population Screening Typical Customers
Table 14. Population Screening Typical Distributors
Table 15. By Type, Global Population Screening Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Population Screening Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Population Screening Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Population Screening Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Population Screening Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Population Screening Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Population Screening Revenue Market Share, 2018-2029
Table 22. Agilent Technologies, Inc. Company Information, Head Office, Market Area and Industry Position
Table 23. Agilent Technologies, Inc. Company Profile and Main Business
Table 24. Agilent Technologies, Inc. Population Screening Models, Specifications and Application
Table 25. Agilent Technologies, Inc. Population Screening Revenue and Gross Margin, 2018-2023
Table 26. Agilent Technologies, Inc. Recent Developments
Table 27. ARUP Laboratories Company Information, Head Office, Market Area and Industry Position
Table 28. ARUP Laboratories Company Profile and Main Business
Table 29. ARUP Laboratories Population Screening Models, Specifications and Application
Table 30. ARUP Laboratories Population Screening Revenue and Gross Margin, 2018-2023
Table 31. ARUP Laboratories Recent Developments
Table 32. F. Hoffmann-La Roche Ltd. Company Information, Head Office, Market Area and Industry Position
Table 33. F. Hoffmann-La Roche Ltd. Company Profile and Main Business
Table 34. F. Hoffmann-La Roche Ltd. Population Screening Models, Specifications and Application
Table 35. F. Hoffmann-La Roche Ltd. Population Screening Revenue and Gross Margin, 2018-2023
Table 36. F. Hoffmann-La Roche Ltd. Recent Developments
Table 37. Gene by Gene, Ltd. Company Information, Head Office, Market Area and Industry Position
Table 38. Gene by Gene, Ltd. Company Profile and Main Business
Table 39. Gene by Gene, Ltd. Population Screening Models, Specifications and Application
Table 40. Gene by Gene, Ltd. Population Screening Revenue and Gross Margin, 2018-2023
Table 41. Gene by Gene, Ltd. Recent Developments
Table 42. Illumina, Inc. Company Information, Head Office, Market Area and Industry Position
Table 43. Illumina, Inc. Company Profile and Main Business
Table 44. Illumina, Inc. Population Screening Models, Specifications and Application
Table 45. Illumina, Inc. Population Screening Revenue and Gross Margin, 2018-2023
Table 46. Illumina, Inc. Recent Developments
Table 47. QIAGEN Company Information, Head Office, Market Area and Industry Position
Table 48. QIAGEN Company Profile and Main Business
Table 49. QIAGEN Population Screening Models, Specifications and Application
Table 50. QIAGEN Population Screening Revenue and Gross Margin, 2018-2023
Table 51. QIAGEN Recent Developments
Table 52. Quest Diagnostics Company Information, Head Office, Market Area and Industry Position
Table 53. Quest Diagnostics Company Profile and Main Business
Table 54. Quest Diagnostics Population Screening Models, Specifications and Application
Table 55. Quest Diagnostics Population Screening Revenue and Gross Margin, 2018-2023
Table 56. Quest Diagnostics Recent Developments
Table 57. LGC Limited Company Information, Head Office, Market Area and Industry Position
Table 58. LGC Limited Company Profile and Main Business
Table 59. LGC Limited Population Screening Models, Specifications and Application
Table 60. LGC Limited Population Screening Revenue and Gross Margin, 2018-2023
Table 61. LGC Limited Recent Developments
Table 62. Novogene Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 63. Novogene Co., Ltd. Company Profile and Main Business
Table 64. Novogene Co., Ltd. Population Screening Models, Specifications and Application
Table 65. Novogene Co., Ltd. Population Screening Revenue and Gross Margin, 2018-2023
Table 66. Novogene Co., Ltd. Recent Developments
Table 67. Thermo Fisher Scientific, Inc. Company Information, Head Office, Market Area and Industry Position
Table 68. Thermo Fisher Scientific, Inc. Company Profile and Main Business
Table 69. Thermo Fisher Scientific, Inc. Population Screening Models, Specifications and Application
Table 70. Thermo Fisher Scientific, Inc. Population Screening Revenue and Gross Margin, 2018-2023
Table 71. Thermo Fisher Scientific, Inc. Recent Developments
List of Figure
Figure 1. Population Screening Picture
Figure 2. Global Population Screening Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Population Screening Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Population Screening Market Share of Global
Figure 5. Global Population Screening Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Population Screening Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Population Screening Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Population Screening Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Population Screening Industry Chain
Figure 10. Hardware Equipment (Instrument, Kits, Chips)
Figure 11. Testing / Lab (Services)
Figure 12. Analytics / Interpretation (Personalization And Interpretation)
Figure 13. By Type, Global Population Screening Revenue, 2018-2029, US$ Million
Figure 14. By Type, Global Population Screening Revenue Market Share, 2018-2029
Figure 15. Hospitals
Figure 16. Research Institutes
Figure 17. Diagnostic Labs
Figure 18. By Application, Global Population Screening Revenue, 2018-2029, US$ Million
Figure 19. By Application, Global Population Screening Revenue Market Share, 2018-2029
Figure 20. By Region, Global Population Screening Revenue Market Share, 2018-2029
Figure 21. North America Population Screening Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, North America Population Screening Revenue Market Share, 2018-2023
Figure 23. Europe Population Screening Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, Europe Population Screening Revenue Market Share, 2018-2023
Figure 25. Asia Pacific Population Screening Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country/Region, Asia Pacific Population Screening Revenue Market Share, 2018-2023
Figure 27. South America Population Screening Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, South America Population Screening Revenue Market Share, 2018-2023
Figure 29. Middle East & Africa Population Screening Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. U.S. Population Screening Revenue, 2018-2029, (US$ Million)
Figure 31. By Company, U.S. Population Screening Market Share, 2018-2023
Figure 32. By Type, U.S. Population Screening Revenue Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Population Screening Revenue Market Share, 2022 VS 2029
Figure 34. Europe Population Screening Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, Europe Population Screening Market Share, 2018-2023
Figure 36. By Type, Europe Population Screening Revenue Market Share, 2022 VS 2029
Figure 37. By Application, Europe Population Screening Revenue Market Share, 2022 VS 2029
Figure 38. China Population Screening Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, China Population Screening Market Share, 2018-2023
Figure 40. By Type, China Population Screening Revenue Market Share, 2022 VS 2029
Figure 41. By Application, China Population Screening Revenue Market Share, 2022 VS 2029
Figure 42. Japan Population Screening Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, Japan Population Screening Market Share, 2018-2023
Figure 44. By Type, Japan Population Screening Revenue Market Share, 2022 VS 2029
Figure 45. By Application, Japan Population Screening Revenue Market Share, 2022 VS 2029
Figure 46. South Korea Population Screening Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, South Korea Population Screening Market Share, 2018-2023
Figure 48. By Type, South Korea Population Screening Revenue Market Share, 2022 VS 2029
Figure 49. By Application, South Korea Population Screening Revenue Market Share, 2022 VS 2029
Figure 50. Southeast Asia Population Screening Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, Southeast Asia Population Screening Market Share, 2018-2023
Figure 52. By Type, Southeast Asia Population Screening Revenue Market Share, 2022 VS 2029
Figure 53. By Application, Southeast Asia Population Screening Revenue Market Share, 2022 VS 2029
Figure 54. India Population Screening Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, India Population Screening Market Share, 2018-2023
Figure 56. By Type, India Population Screening Revenue Market Share, 2022 VS 2029
Figure 57. By Application, India Population Screening Revenue Market Share, 2022 VS 2029
Figure 58. Middle East & Asia Population Screening Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, Middle East & Asia Population Screening Market Share, 2018-2023
Figure 60. By Type, Middle East & Asia Population Screening Revenue Market Share, 2022 VS 2029
Figure 61. By Application, Middle East & Asia Population Screening Revenue Market Share, 2022 VS 2029
Figure 62. Research Methodology
Figure 63. Breakdown of Primary Interviews
Figure 64. Bottom-up Approaches
Figure 65. Top-down Approaches
Reason to Buy
- Current and future of Service & Software Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Service & Software Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Service & Software Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Service & Software Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets